サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1777377

IVD受託製造の世界市場

IVD Contract Manufacturing

出版日
ページ情報
英文 378 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.79円
IVD受託製造の世界市場
出版日: 2025年07月28日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 378 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

IVD受託製造の世界市場は2030年までに295億米ドルに到達

2024年に167億米ドルと推定されるIVD受託製造の世界市場は、2024年から2030年にかけてCAGR 10.0％で成長し、2030年には295億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである消耗品は、CAGR 8.5%を記録し、分析期間終了時には172億米ドルに達すると予測されます。機器セグメントの成長率は、分析期間中CAGR 12.4％と推定されます。

米国市場は推定45億米ドル、中国はCAGR13.4%で成長予測

米国のIVD受託製造市場は、2024年に45億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに60億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは13.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.3%と8.7%と予測されています。欧州では、ドイツがCAGR 7.8%で成長すると予測されています。

IVD受託製造市場- 主要動向と促進要因のまとめ

体外診断用医薬品（IVD）の受託製造は、世界の診断産業にとって不可欠なものとなっており、医療機器メーカーは試薬、消耗品、診断機器の製造を専門の第三者メーカーに委託できるようになっています。迅速で正確な診断ソリューションへの需要が高まる中、IVD企業は製造受託機関（CMO）や開発・製造受託機関（CDMO）を活用し、生産規模の拡大、コストの最適化、市場参入の迅速化を図る動きが加速しています。分子診断薬、イムノアッセイ、POCT、コンパニオン診断薬の複雑化により、高品質で規制に準拠した受託製造ソリューションの必要性がさらに高まっています。

精密医療、デジタル診断、ラボ検査の自動化の拡大が体外診断薬業界を再構築しており、アッセイ開発、試薬処方、機器組み立てのアウトソーシングが拡大しています。ヘルスケアプロバイダーは、より迅速で費用対効果が高く、スケーラブルな検査ソリューションを求めており、急速に進化する市場で競争力を維持しようとする企業にとって、IVD受託製造は戦略的に必要なものとなりつつあります。

技術の進歩はIVD受託製造をどのように強化していますか？

IVD受託製造の分野では、生産効率、品質管理、スケーラビリティを向上させるための技術的な進歩が著しく進んでいます。最も重要な技術革新の一つは、製造ワークフローへの自動化とロボット工学の統合です。自動化システムは現在、リキッドハンドリング、試薬分注、ハイスループットアッセイ製造に使用され、人的ミスを減らし、プロセスの一貫性を高めています。これは特に、精度と再現性が極めて重要な分子診断キット、ラテラルフローアッセイ、イムノアッセイに有益です。

もう一つの大きなブレークスルーは、体外診断用医薬品試薬やアッセイコンポーネントの製造にシングルユース・バイオプロセシング技術を採用したことです。使い捨てバイオリアクター、マイクロ流体チップ、充填済み試薬カートリッジの使用により、無菌性、汚染管理、バッチ間の一貫性が改善され、受託製造がより効率的でコスト効率の高いものとなっています。さらに、3Dプリンティングと微細加工の進歩により、診断機器の迅速な試作とカスタマイズが可能になり、次世代IVDソリューションの開発サイクルが加速しています。

分子診断学と個別化医療の台頭は、カスタムアッセイ開発とバイオマーカーに基づく検査製造の改善にもつながっています。IVD受託製造業者は現在、ハイスループット・シーケンス（NGS）、CRISPRベースのアッセイ、デジタルPCR（dPCR）プラットフォームを活用して、腫瘍学、感染症、遺伝性疾患に合わせた特殊な診断ソリューションを開発しています。さらに、人工知能（AI）と機械学習を品質管理プロセスに組み込むことで、受託製造施設におけるリアルタイムモニタリング、予知保全、バッチ最適化が改善されつつあります。

IVD受託製造の成長を促進する市場動向とは？

いくつかの主要動向がIVD受託製造業界を形成し、アウトソーシングの拡大と技術革新を促進しています。最も重要な動向の一つは、ポイントオブケア検査（POCT）と分散型診断への需要の高まりです。従来の検査室ベースの検査から、ポータブルで迅速、ユーザーフレンドリーな診断ソリューションへのシフトは、ラテラルフローアッセイ、マイクロ流体検査ストリップ、ハンドヘルド分子診断薬の製造委託パートナーシップの急増につながっています。疾病の早期発見と遠隔地ヘルスケアを重視する世界の取り組みにより、IVD企業はスケーラブルで高品質な製造に精通した専門CMOにPOCTの製造を委託しています。

もう一つの大きなトレンドは、精密医療や標的治療の台頭に対応した分子診断薬やコンパニオン診断薬の拡大です。製薬企業やバイオテクノロジー企業は、遺伝子やバイオマーカーのプロファイリングに基づいて個別化された治療法の選択を可能にするコンパニオン診断薬（CDx）を開発するために、体外診断薬メーカーとの協力関係をますます強めています。このため、PCRベース、次世代シーケンシング（NGS）、CRISPR対応の診断アッセイを商業規模で製造できる高度に専門化された受託製造サービスへのニーズが高まっています。

IVD製造における規制の複雑化も、企業を製造委託ソリューションへと向かわせています。診断機器に対するFDA、EMA、ISO 13485の要求事項が厳しくなる中、多くの企業は確立された規制の専門知識、検証された製造ライン、適正製造基準（GMP）に準拠した施設を持つ経験豊富なCDMOと提携しています。生産をアウトソーシングすることで、IVD企業は規制当局の承認を迅速化し、コンプライアンス・リスクを低減し、世界市場で一貫した品質管理を確保することができます。

さらに、サプライチェーンの最適化とコスト削減の圧力により、体外診断用医薬品企業は、原材料の調達、試薬の調合、デバイスの組み立てを、調達ネットワークが確立され、コスト効率の高い生産能力を持つCMOに委託するようになっています。世界のサプライチェーンの混乱が増加する中、メーカーは製品の安定供給を確保するため、現地生産、二重調達戦略、柔軟な製造能力を提供する契約パートナーを求めています。

IVD受託製造市場の成長の原動力は？

IVD受託製造市場は、迅速診断に対する需要の増加、ヘルスケアのアウトソーシング動向、診断技術の進歩など、いくつかの主要な成長促進要因によって急速に拡大しています。市場成長を後押しする主な要因の一つは、感染症、腫瘍バイオマーカー、遺伝性疾患の検出における分子・免疫診断検査の広範な採用です。人口の高齢化、慢性疾患の増加、世界のパンデミックへの備えを背景に、高スループットで信頼性が高く、費用対効果の高い診断ソリューションへのニーズが急増しており、IVD企業が大規模生産のために受託製造に依存するようになっています。

もう一つの大きな成長要因は、中小規模のバイオテクノロジー企業による受託製造の採用が増加していることです。多くの新興企業や新興診断薬企業は自社での製造能力を欠いており、代わりにCMOを活用して製造規模を拡大し、規制上の課題を克服し、市場参入を加速しています。経験豊富なIVD受託製造業者と提携することで、これらの企業は高品質でGMPに準拠した製造を確保しながら、研究とイノベーションに集中することができます。

診断薬におけるAIとデジタルトランスフォーメーションの役割の増大も、カスタマイズされた受託製造ソリューションの必要性を煽っています。AIを活用した診断薬、クラウドベースの検査管理プラットフォーム、ウェアラブルバイオセンサーが普及するにつれ、IVDメーカーはスマート製造、自動品質管理、リアルタイム分析に精通した受託製造パートナーを必要としています。これらの次世代製造ソリューションは、企業の生産合理化、検査精度の向上、拡張性の強化を支援しています。

さらに、IVD製造拠点の地理的拡大が市場成長を後押ししています。米国、欧州、日本が引き続き診断薬イノベーションをリードしている一方で、アジア太平洋諸国（中国、インド、韓国、シンガポール）は、コスト優位性、熟練労働力、バイオテクノロジーや医療技術への投資を支援する有利な政府政策により、主要な受託製造先として台頭しつつあります。世界のIVD企業の多くは、より低い製造コスト、強力なインフラ、大量生産能力の恩恵を受けるため、製造拠点をアジア太平洋に移しています。

最後に、持続可能性と環境に配慮した製造への注目の高まりが、IVD受託製造の状況を変えつつあります。企業は、廃棄物を最小限に抑え、二酸化炭素排出量を削減し、環境規制を遵守するために、環境に優しい製造技術、生分解性試験部品、エネルギー効率の高い製造プロセスを模索しています。診断薬メーカーやヘルスケアプロバイダーにとって、持続可能性が重要な課題となっている、

セグメント

タイプ（消耗品、機器）、技術（免疫測定、臨床化学、分子診断、微生物学、血液学、凝固・止血、その他）、サービス（製造、アッセイ開発、その他）

調査対象企業の例

  • Advanced Powder Products, Inc.
  • Argonaut Manufacturing Services
  • Avioq, Inc.
  • Beacon MedTech Solutions
  • Bio-Techne
  • Celestica Inc.
  • Donatelle
  • ERREKA Medical
  • Eurogentec
  • Fujirebio
  • Grand River Aseptic Manufacturing（GRAM）
  • Invetech
  • IRP Medical
  • IVD Research, Inc.
  • Jabil Inc.
  • Newland AIDC
  • Qosina
  • Sanmina Corporation
  • TE Connectivity
  • West Pharmaceutical Services, Inc.

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31706

Global IVD Contract Manufacturing Market to Reach US$29.5 Billion by 2030

The global market for IVD Contract Manufacturing estimated at US$16.7 Billion in the year 2024, is expected to reach US$29.5 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$17.2 Billion by the end of the analysis period. Growth in the Equipment segment is estimated at 12.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.5 Billion While China is Forecast to Grow at 13.4% CAGR

The IVD Contract Manufacturing market in the U.S. is estimated at US$4.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.0 Billion by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.3% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

IVD Contract Manufacturing Market - Key Trends & Drivers Summarized

In-vitro diagnostics (IVD) contract manufacturing has become an essential part of the global diagnostic industry, enabling medical device companies to outsource the production of reagents, consumables, and diagnostic instruments to specialized third-party manufacturers. With the rising demand for rapid and accurate diagnostic solutions, IVD companies are increasingly turning to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs) to scale production, optimize costs, and accelerate market entry. The growing complexity of molecular diagnostics, immunoassays, point-of-care testing (POCT), and companion diagnostics has further fueled the need for high-quality, regulatory-compliant contract manufacturing solutions.

The expansion of precision medicine, digital diagnostics, and automation in laboratory testing is reshaping the IVD landscape, leading to greater outsourcing of assay development, reagent formulation, and device assembly. With healthcare providers demanding faster, cost-effective, and scalable testing solutions, IVD contract manufacturing is becoming a strategic necessity for companies looking to stay competitive in a rapidly evolving market.

How Are Technological Advancements Enhancing IVD Contract Manufacturing?

The IVD contract manufacturing sector is experiencing significant technological advancements aimed at improving production efficiency, quality control, and scalability. One of the most critical innovations is the integration of automation and robotics into manufacturing workflows. Automated systems are now being used for liquid handling, reagent dispensing, and high-throughput assay production, reducing human error and enhancing process consistency. This is particularly beneficial for molecular diagnostic kits, lateral flow assays, and immunoassays, where precision and reproducibility are crucial.

Another major breakthrough is the adoption of single-use bioprocessing technologies for the manufacturing of IVD reagents and assay components. The use of disposable bioreactors, microfluidic chips, and pre-filled reagent cartridges has improved sterility, contamination control, and batch-to-batch consistency, making contract manufacturing more efficient and cost-effective. Additionally, advances in 3D printing and microfabrication are enabling the rapid prototyping and customization of diagnostic devices, accelerating the development cycle for next-generation IVD solutions.

The rise of molecular diagnostics and personalized medicine has also led to improvements in custom assay development and biomarker-based test manufacturing. IVD contract manufacturers are now utilizing high-throughput sequencing (NGS), CRISPR-based assays, and digital PCR (dPCR) platforms to develop specialized diagnostic solutions tailored to oncology, infectious diseases, and genetic disorders. Moreover, the incorporation of artificial intelligence (AI) and machine learning into quality control processes is improving real-time monitoring, predictive maintenance, and batch optimization in contract manufacturing facilities.

What Market Trends Are Driving the Growth of IVD Contract Manufacturing?

Several key trends are shaping the IVD contract manufacturing industry, driving increased outsourcing and technological innovation. One of the most significant trends is the growing demand for point-of-care testing (POCT) and decentralized diagnostics. The shift from traditional laboratory-based testing to portable, rapid, and user-friendly diagnostic solutions has led to a surge in contract manufacturing partnerships for lateral flow assays, microfluidic test strips, and handheld molecular diagnostics. With global health initiatives emphasizing early disease detection and remote healthcare, IVD companies are outsourcing POCT production to specialized CMOs with expertise in scalable, high-quality manufacturing.

Another major trend is the expansion of molecular and companion diagnostics in response to the rise of precision medicine and targeted therapies. Pharmaceutical companies and biotech firms are increasingly collaborating with IVD manufacturers to develop companion diagnostics (CDx) that enable personalized treatment selection based on genetic and biomarker profiling. This has fueled the need for highly specialized contract manufacturing services that can produce PCR-based, next-generation sequencing (NGS), and CRISPR-enabled diagnostic assays at commercial scale.

The increasing regulatory complexity in IVD manufacturing is also driving companies toward outsourced production solutions. With stricter FDA, EMA, and ISO 13485 requirements for diagnostic devices, many companies are partnering with experienced CDMOs that have established regulatory expertise, validated production lines, and Good Manufacturing Practice (GMP)-compliant facilities. By outsourcing production, IVD firms can accelerate regulatory approvals, reduce compliance risks, and ensure consistent quality control across global markets.

Additionally, supply chain optimization and cost reduction pressures are leading IVD companies to outsource raw material sourcing, reagent formulation, and device assembly to CMOs with well-established procurement networks and cost-efficient production capabilities. With the rise of global supply chain disruptions, manufacturers are seeking contract partners that offer localized production, dual-sourcing strategies, and flexible manufacturing capacities to ensure uninterrupted product availability.

What Is Driving the Growth of the IVD Contract Manufacturing Market?

The IVD contract manufacturing market is expanding rapidly due to several key growth drivers, including increased demand for rapid diagnostics, outsourcing trends in healthcare, and advancements in diagnostic technology. One of the primary factors propelling market growth is the widespread adoption of molecular and immunodiagnostic tests in the detection of infectious diseases, oncology biomarkers, and genetic disorders. With an aging population, rising prevalence of chronic diseases, and global pandemic preparedness, the need for high-throughput, reliable, and cost-effective diagnostic solutions has surged, leading IVD companies to rely on contract manufacturing for large-scale production.

Another major growth driver is the rising adoption of contract manufacturing by small and mid-sized biotech firms. Many startups and emerging diagnostic companies lack in-house manufacturing capabilities and instead leverage CMOs to scale up production, navigate regulatory challenges, and accelerate market entry. By partnering with experienced IVD contract manufacturers, these companies can focus on research and innovation while ensuring high-quality, GMP-compliant production.

The increasing role of AI and digital transformation in diagnostics is also fueling the need for customized contract manufacturing solutions. As AI-powered diagnostics, cloud-based test management platforms, and wearable biosensors gain traction, IVD manufacturers require contract production partners with expertise in smart manufacturing, automated quality control, and real-time analytics. These next-generation manufacturing solutions are helping companies streamline production, improve test accuracy, and enhance scalability.

Additionally, the geographic expansion of IVD manufacturing hubs is driving market growth. While the U.S., Europe, and Japan continue to lead in diagnostic innovation, countries in Asia-Pacific (China, India, South Korea, and Singapore) are emerging as key contract manufacturing destinations due to their cost advantages, skilled labor force, and favorable government policies supporting biotech and medtech investments. Many global IVD companies are shifting manufacturing operations to Asia-Pacific to benefit from lower production costs, strong infrastructure, and high-volume manufacturing capabilities.

Lastly, the increasing focus on sustainability and green manufacturing is reshaping the IVD contract manufacturing landscape. Companies are exploring eco-friendly production techniques, biodegradable test components, and energy-efficient manufacturing processes to minimize waste, reduce carbon footprints, and comply with environmental regulations. As sustainability becomes a key consideration for diagnostic manufacturers and healthcare providers,

SCOPE OF STUDY:

The report analyzes the IVD Contract Manufacturing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Consumables, Equipment); Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others); Service (Manufacturing, Assay Development, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Advanced Powder Products, Inc.
  • Argonaut Manufacturing Services
  • Avioq, Inc.
  • Beacon MedTech Solutions
  • Bio-Techne
  • Celestica Inc.
  • Donatelle
  • ERREKA Medical
  • Eurogentec
  • Fujirebio
  • Grand River Aseptic Manufacturing (GRAM)
  • Invetech
  • IRP Medical
  • IVD Research, Inc.
  • Jabil Inc.
  • Newland AIDC
  • Qosina
  • Sanmina Corporation
  • TE Connectivity
  • West Pharmaceutical Services, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • IVD Contract Manufacturing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • OEM Outsourcing Strategies Accelerate Demand for End-to-End IVD Contract Manufacturing Services
    • Rising Pressure to Reduce Time-to-Market Drives Partnerships With Agile IVD CMOs
    • Surge in POC, Rapid, and Home Diagnostics Expands Need for Scalable, Flexible Manufacturing Capacity
    • Demand for OEM-Integrated Design-to-Scale Manufacturing Models Strengthens Business Case for CDMOs
    • Regulatory Complexity Across Global Markets Spurs Need for cGMP- and ISO-13485-Certified IVD Manufacturers
    • Growth in Molecular Diagnostics and PCR Platforms Boosts Demand for Specialized Assay and Cartridge Manufacturing
    • OEM Focus on Core Competency Retention Drives Strategic Outsourcing of Reagent and Consumable Production
    • Increasing Importance of Disposable Cassette and Microfluidic Device Production Fuels Market Differentiation
    • Rising Investment in Companion Diagnostics and Personalized Medicine Expands Scope of IVD CMO Engagements
    • Adoption of Digital Health and Remote Monitoring Platforms Drives Integration of IVD Hardware-Software Assemblies
    • Biotech and Start-Up Diagnostics Firms Leverage CMOs for Pilot-Through-Commercial Scaling
    • Emerging Need for Multiplex and Multi-Pathogen Test Manufacturing Supports Assay Customization Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World IVD Contract Manufacturing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for IVD Contract Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Assay Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Assay Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Assay Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Immunoassay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Immunoassay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Microbiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Microbiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Coagulation & Hemostasis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Coagulation & Hemostasis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • JAPAN
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • CHINA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • EUROPE
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for IVD Contract Manufacturing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • FRANCE
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • GERMANY
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 125: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 134: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for IVD Contract Manufacturing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 164: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • INDIA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 173: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for IVD Contract Manufacturing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for IVD Contract Manufacturing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for IVD Contract Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 260: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 269: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 287: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030
  • AFRICA
    • IVD Contract Manufacturing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 305: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Type - Consumables and Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for IVD Contract Manufacturing by Type - Consumables and Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for IVD Contract Manufacturing by Type - Percentage Breakdown of Value Sales for Consumables and Equipment for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for IVD Contract Manufacturing by Service - Manufacturing, Assay Development and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for IVD Contract Manufacturing by Service - Percentage Breakdown of Value Sales for Manufacturing, Assay Development and Other Services for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for IVD Contract Manufacturing by Technology - Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for IVD Contract Manufacturing by Technology - Percentage Breakdown of Value Sales for Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION